Quarterly report pursuant to Section 13 or 15(d)

DERIVATIVE FINANCIAL INSTRUMENTS AND WARRANT LIABILITIES (Details - Activity associated with warrants)

v3.24.2.u1
DERIVATIVE FINANCIAL INSTRUMENTS AND WARRANT LIABILITIES (Details - Activity associated with warrants)
6 Months Ended
Jun. 30, 2024
USD ($)
Derivative Instruments, Gain (Loss) [Line Items]  
Fair value on December 31, 2023 $ 5,971,067
Loss on changes in fair value 14,893,051
Exercise of warrants (17,387,486)
Reclassification to equity (3,405,662)
Balance at June 30, 2024 70,970
Series A Warrants [Member]  
Derivative Instruments, Gain (Loss) [Line Items]  
Fair value on December 31, 2023 4,705,245
Loss on changes in fair value 12,718,378
Exercise of warrants (17,352,653)
Reclassification to equity 0
Balance at June 30, 2024 70,970
Series B Warrants [Member]  
Derivative Instruments, Gain (Loss) [Line Items]  
Fair value on December 31, 2023 1,265,822
Loss on changes in fair value 2,174,673
Exercise of warrants (34,833)
Reclassification to equity (3,405,662)
Balance at June 30, 2024 $ 0